Latest Sandu Pharmaceuticals stock price
Sandu Pharmaceuticals P/E Ratio
SANDUPHQ • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
25.08
High Valuation
High - Growth expectations or overvalued
Current Valuation Metrics
P/E Ratio
25.08
Current Price
₹40.13
EPS (TTM)
₹1.60
Exchange
BSE
Valuation Signal
Signal
Overvalued
Historical Avg
38.78
Historical Range
17.3 - 59.22
Percentile
33.3%
Sector Context
Sector Average
53.4
Sector Median
31.12
Sector Rank
#11 of 132
Sector Percentile
8.3%
Earnings Breakdown (TTM)
TTM EPS
₹3.08
Mar 2025
₹0.34
Sept 2024
₹1.95
Key P/E Ratio Insights for Sandu Pharmaceuticals
- Stock appears overvalued with PE of 25.08, suggesting caution for new investments
- Current PE is 35.3% below historical average
- Trading at discount to sector average PE of 53.4
View the SANDUPHQ equity price for detailed stock performance.
P/E Ratio Historical Trend for Sandu Pharmaceuticals
Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.
Related Pages for Sandu Pharmaceuticals
Additional stock information and data for SANDUPHQ
Historical P/E Ratio Data
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 17.3 | 3.31 | ₹57.26 | BSE | Moderate |
| 2023 | 59.22 | 1.15 | ₹68.10 | BSE | High |
| 2022 | 39.82 | 1.68 | ₹66.90 | BSE | High |
Sector P/E Ratio Comparison
Comparing Sandu Pharmaceuticals with other companies in Healthcare sector
Sector Average
53.4
Sector Median
31.12
Lowest P/E
1.5
Highest P/E
628.04
Companies
132
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |